Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

MACH discovered by Weizmann Institute

June 28, 1996

Gabitril approved in France as add-on therapy

June 28, 1996

Depakote receives FDA approval for new indication

June 28, 1996

Gensia's GP-3269 in phase I

June 28, 1996

TV-1901 demonstrates efficiency and safety

June 28, 1996

Brain monoamine partial agonists/antagonists claimed by Neurogen

June 28, 1996

DuPont Merck and Richwood enter marketing agreement

June 28, 1996

Fujisawa discloses bradykinin antagonists

June 28, 1996

Asahi Brewery discloses antioxidants

June 21, 1996

Schering AG claims AMPA antagonists for neurodegenerative disorders

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 12, 2025.
Could restricting diversity efforts stall women’s health research?
BioWorld
Recent progress in redressing the historical underfunding and neglect of women’s health could be undermined by the backlash against diversity, equity and...
Alkermes’ alixorexton hits endpoints in narcolepsy phase II
BioWorld
Alkermes plc’s placebo-controlled phase II study of alixorexton in treating narcolepsy type 2 (NT2) hit its dual primary endpoints, producing statistically...
Pazdur ‘optimal fit’ to lead FDA’s CDER
BioWorld
In reaching within to name 26-year FDA veteran Richard Pazdur as the next CDER director, FDA Commissioner Marty Makary likely chose the best possible person to...